Liposomal Doxorubicin Market in U.S. to Surpass US$ 192.9 Million by 2027, Says Coherent Market Insights (CMI)
09 juil. 2021 08h40 HE
|
CMI
SEATTLE, July 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. liposomal doxorubicin market is estimated to be valued at US$ 140.0 Million in 2020 and is expected to...